Lyra Therapeutics (NASDAQ: LYRA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 139.62% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $6.26 last updated August 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.